Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: Systematic review and meta-analysis

Lucio De Maria, Paolo De Sanctis, Megha M Tollefson, Samir Mardini, James A. Garrity, Pearse P. Morris, Emily Bendel, Waleed Brinjikji

Research output: Contribution to journalReview article

Abstract

Percutaneous sclerotherapy is an alternative strategy for the treatment of vascular malformations of the orbital and periorbital regions. The safety and efficacy of sclerotherapy in this setting have not been fully established. We present the results of a systematic review and meta-analysis examining the safety and efficacy of percutaneous sclerotherapy for the treatment of vascular malformations of the orbit. We searched PubMed, MEDLINE, and EMBASE from 2000 to 2018 for studies evaluating the safety and efficacy of percutaneous sclerotherapy for orbital and periorbital vascular malformations. Two independent reviewers selected studies and abstracted data. The primary outcome of this study is the efficacy of sclerotherapy which includes complete response, partial response, or no response to sclerotherapy. Data were analyzed using random-effects meta-analysis. Thirteen studies reporting on 154 patients were included. The rate of complete cure after percutaneous sclerotherapy was 54.9% (95% confidence interval [CI] = 34.2%-75.7%). The rate of emergent decompressive surgery was 3.4% (95% CI = 0.5%-6.2%), and the rate of vision loss was 2.7% (95% CI = 0.1%-5.3%). I2 values were above 50% for most outcomes indicating substantial heterogeneity. Our systematic review and meta-analysis of 13 studies and over 150 patients found that percutaneous sclerotherapy is a safe and effective treatment modality for the treatment of low-flow vascular malformations of the orbit.

Original languageEnglish (US)
JournalSurvey of ophthalmology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Vascular Malformations
Sclerotherapy
Meta-Analysis
Orbit
Confidence Intervals
Safety
Therapeutics
PubMed
MEDLINE
Outcome Assessment (Health Care)

Keywords

  • low-flow vascular malformations
  • lymphatic malformations
  • meta-analysis
  • orbit
  • sclerotherapy
  • systematic review
  • venous malformations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions : Systematic review and meta-analysis. / De Maria, Lucio; De Sanctis, Paolo; Tollefson, Megha M; Mardini, Samir; Garrity, James A.; Morris, Pearse P.; Bendel, Emily; Brinjikji, Waleed.

In: Survey of ophthalmology, 01.01.2019.

Research output: Contribution to journalReview article

@article{cd52fd6912834c7392c3b793294866c9,
title = "Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: Systematic review and meta-analysis",
abstract = "Percutaneous sclerotherapy is an alternative strategy for the treatment of vascular malformations of the orbital and periorbital regions. The safety and efficacy of sclerotherapy in this setting have not been fully established. We present the results of a systematic review and meta-analysis examining the safety and efficacy of percutaneous sclerotherapy for the treatment of vascular malformations of the orbit. We searched PubMed, MEDLINE, and EMBASE from 2000 to 2018 for studies evaluating the safety and efficacy of percutaneous sclerotherapy for orbital and periorbital vascular malformations. Two independent reviewers selected studies and abstracted data. The primary outcome of this study is the efficacy of sclerotherapy which includes complete response, partial response, or no response to sclerotherapy. Data were analyzed using random-effects meta-analysis. Thirteen studies reporting on 154 patients were included. The rate of complete cure after percutaneous sclerotherapy was 54.9{\%} (95{\%} confidence interval [CI] = 34.2{\%}-75.7{\%}). The rate of emergent decompressive surgery was 3.4{\%} (95{\%} CI = 0.5{\%}-6.2{\%}), and the rate of vision loss was 2.7{\%} (95{\%} CI = 0.1{\%}-5.3{\%}). I2 values were above 50{\%} for most outcomes indicating substantial heterogeneity. Our systematic review and meta-analysis of 13 studies and over 150 patients found that percutaneous sclerotherapy is a safe and effective treatment modality for the treatment of low-flow vascular malformations of the orbit.",
keywords = "low-flow vascular malformations, lymphatic malformations, meta-analysis, orbit, sclerotherapy, systematic review, venous malformations",
author = "{De Maria}, Lucio and {De Sanctis}, Paolo and Tollefson, {Megha M} and Samir Mardini and Garrity, {James A.} and Morris, {Pearse P.} and Emily Bendel and Waleed Brinjikji",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.survophthal.2019.08.003",
language = "English (US)",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions

T2 - Systematic review and meta-analysis

AU - De Maria, Lucio

AU - De Sanctis, Paolo

AU - Tollefson, Megha M

AU - Mardini, Samir

AU - Garrity, James A.

AU - Morris, Pearse P.

AU - Bendel, Emily

AU - Brinjikji, Waleed

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Percutaneous sclerotherapy is an alternative strategy for the treatment of vascular malformations of the orbital and periorbital regions. The safety and efficacy of sclerotherapy in this setting have not been fully established. We present the results of a systematic review and meta-analysis examining the safety and efficacy of percutaneous sclerotherapy for the treatment of vascular malformations of the orbit. We searched PubMed, MEDLINE, and EMBASE from 2000 to 2018 for studies evaluating the safety and efficacy of percutaneous sclerotherapy for orbital and periorbital vascular malformations. Two independent reviewers selected studies and abstracted data. The primary outcome of this study is the efficacy of sclerotherapy which includes complete response, partial response, or no response to sclerotherapy. Data were analyzed using random-effects meta-analysis. Thirteen studies reporting on 154 patients were included. The rate of complete cure after percutaneous sclerotherapy was 54.9% (95% confidence interval [CI] = 34.2%-75.7%). The rate of emergent decompressive surgery was 3.4% (95% CI = 0.5%-6.2%), and the rate of vision loss was 2.7% (95% CI = 0.1%-5.3%). I2 values were above 50% for most outcomes indicating substantial heterogeneity. Our systematic review and meta-analysis of 13 studies and over 150 patients found that percutaneous sclerotherapy is a safe and effective treatment modality for the treatment of low-flow vascular malformations of the orbit.

AB - Percutaneous sclerotherapy is an alternative strategy for the treatment of vascular malformations of the orbital and periorbital regions. The safety and efficacy of sclerotherapy in this setting have not been fully established. We present the results of a systematic review and meta-analysis examining the safety and efficacy of percutaneous sclerotherapy for the treatment of vascular malformations of the orbit. We searched PubMed, MEDLINE, and EMBASE from 2000 to 2018 for studies evaluating the safety and efficacy of percutaneous sclerotherapy for orbital and periorbital vascular malformations. Two independent reviewers selected studies and abstracted data. The primary outcome of this study is the efficacy of sclerotherapy which includes complete response, partial response, or no response to sclerotherapy. Data were analyzed using random-effects meta-analysis. Thirteen studies reporting on 154 patients were included. The rate of complete cure after percutaneous sclerotherapy was 54.9% (95% confidence interval [CI] = 34.2%-75.7%). The rate of emergent decompressive surgery was 3.4% (95% CI = 0.5%-6.2%), and the rate of vision loss was 2.7% (95% CI = 0.1%-5.3%). I2 values were above 50% for most outcomes indicating substantial heterogeneity. Our systematic review and meta-analysis of 13 studies and over 150 patients found that percutaneous sclerotherapy is a safe and effective treatment modality for the treatment of low-flow vascular malformations of the orbit.

KW - low-flow vascular malformations

KW - lymphatic malformations

KW - meta-analysis

KW - orbit

KW - sclerotherapy

KW - systematic review

KW - venous malformations

UR - http://www.scopus.com/inward/record.url?scp=85072195347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072195347&partnerID=8YFLogxK

U2 - 10.1016/j.survophthal.2019.08.003

DO - 10.1016/j.survophthal.2019.08.003

M3 - Review article

C2 - 31425703

AN - SCOPUS:85072195347

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

ER -